Prisca S. Leferink
Amsterdam, NH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Development of 18F-Labeled PET Tracer Candidates for Imaging of the Abelson Non-receptor Tyrosine Kinase in Parkinson's Disease.
Journal: Journal of medicinal chemistry
Published: September 15, 2023
Core protocol development for phase 2/3 clinical trials in the leukodystrophy vanishing white matter: a consensus statement by the VWM consortium and patient advocates.
Journal: BMC neurology
Published: January 05, 2023
Therapeutic potential of human stem cell transplantations for Vanishing White Matter: A quest for the Goldilocks graft.
Journal: CNS neuroscience & therapeutics
Published: November 12, 2021
Therapy Trial Design in Vanishing White Matter: An Expert Consortium Opinion.
Journal: Neurology. Genetics
Published: September 20, 2021
The Alzheimer's disease drug development landscape.
Journal: Alzheimer's research & therapy
Published: August 04, 2021
Astrocyte Subtype Vulnerability in Stem Cell Models of Vanishing White Matter.
Journal: Annals of neurology
Published: February 13, 2019
Affected astrocytes in the spinal cord of the leukodystrophy vanishing white matter.
Journal: Glia
Published: October 25, 2017
The Healthy and Diseased Microenvironments Regulate Oligodendrocyte Properties: Implications for Regenerative Medicine.
Journal: The American journal of pathology
Published: March 31, 2017
Showing 1-11 of 11
Last Updated: 09/26/2026